Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Biochemical and Biophysical Research Communications
|
September 30, 1991
Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A
K Ferlinz, R Hurwitz, K Sandhoff
Biological Chemistry Hoppe-Seyler
|
July 1, 1994
The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts
R Hurwitz, K Ferlinz, K Sandhoff
American Journal of Physiology. Renal Physiology
|
September 21, 2000
Physiology of apoptosis
E Gulbins, A Jekle, K Ferlinz, et al.
Chemistry and Physics of Lipids
|
September 23, 2000
Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins
K Ferlinz, T Linke, O Bartelsen, et al.
The Biochemical Journal
|
August 1, 1994
Occurrence of two molecular forms of human acid sphingomyelinase
K Ferlinz, R Hurwitz, G Vielhaber, et al.
The Journal of Biological Chemistry
|
February 18, 1994
Processing of human acid sphingomyelinase in normal and I-cell fibroblasts
R Hurwitz, K Ferlinz, G Vielhaber, et al.
Herz
|
September 30, 2018
[Lipid profile and cardiovascular risk of participants in the lipid measurement program in the industrial park in Höchst]
M Christmann, A Rosada, K Ferlinz, et al.
FEBS Letters
|
December 16, 1996
Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence
S Lansmann, K Ferlinz, R Hurwitz, et al.
Journal of Biotechnology
|
October 9, 1998
Expression of recombinant human acid sphingomyelinase in insect Sf21 cells: purification, processing and enzymatic characterization
O Bartelsen, S Lansmann, M Nettersheim, et al.
Human Mutation
|
March 10, 2001
Molecular analysis of acid ceramidase deficiency in patients with Farber disease
J Bär, T Linke, K Ferlinz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Biochemical and Biophysical Research Communications
|
September 30, 1991
Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A
K Ferlinz, R Hurwitz, K Sandhoff
Biological Chemistry Hoppe-Seyler
|
July 1, 1994
The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts
R Hurwitz, K Ferlinz, K Sandhoff
American Journal of Physiology. Renal Physiology
|
September 21, 2000
Physiology of apoptosis
E Gulbins, A Jekle, K Ferlinz, et al.
Chemistry and Physics of Lipids
|
September 23, 2000
Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins
K Ferlinz, T Linke, O Bartelsen, et al.
The Biochemical Journal
|
August 1, 1994
Occurrence of two molecular forms of human acid sphingomyelinase
K Ferlinz, R Hurwitz, G Vielhaber, et al.
The Journal of Biological Chemistry
|
February 18, 1994
Processing of human acid sphingomyelinase in normal and I-cell fibroblasts
R Hurwitz, K Ferlinz, G Vielhaber, et al.
Herz
|
September 30, 2018
[Lipid profile and cardiovascular risk of participants in the lipid measurement program in the industrial park in Höchst]
M Christmann, A Rosada, K Ferlinz, et al.
FEBS Letters
|
December 16, 1996
Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence
S Lansmann, K Ferlinz, R Hurwitz, et al.
Journal of Biotechnology
|
October 9, 1998
Expression of recombinant human acid sphingomyelinase in insect Sf21 cells: purification, processing and enzymatic characterization
O Bartelsen, S Lansmann, M Nettersheim, et al.
Human Mutation
|
March 10, 2001
Molecular analysis of acid ceramidase deficiency in patients with Farber disease
J Bär, T Linke, K Ferlinz, et al.
Page
of 3